$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs

Vertex Pharmaceuticals Inc's (NASDAQ:VRTX) blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some patients by up to 45 years. Despite

BenzingaApr 27 02:34

Vertex Announces European Commission Approval For Kalydeco To Treat Infants With Cystic Fibrosis Ages 1 Month And Older

Vertex Announces European Commission Approval For Kalydeco To Treat Infants With Cystic Fibrosis Ages 1 Month And Older

BenzingaApr 26 23:57

The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals

Yahoo FinanceApr 26 20:25

(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest

Vertex Pharmaceuticals's (NYSE:VRTX) short percent of float has fallen 3.75% since its last report. The company recently reported that it has 3.98 million shares sold short, which is 1.54% of all regu

BenzingaApr 26 02:30

9 Stocks That Thrive When Interest Rates Are Higher

Though economic stress could be on the way, a few groups of stocks can benefit.

BarronsApr 26 02:10

Regeneron to Collaborate on Gene Editing Therapies With Doudna-founded Mammoth

Yahoo FinanceApr 25 19:00